» Articles » PMID: 31338697

Imaging Cardiac Sympathetic Innervation with MIBG: Linear Conversion of the Heart-to-mediastinum Ratio Between Different Collimators

Overview
Journal EJNMMI Phys
Specialty Radiology
Date 2019 Jul 25
PMID 31338697
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The heart-to-mediastinum (H/M) ratio is a commonly used parameter to measure cardiac I-123 metaiodobenzylguanidine (MIBG) uptake. Since the H/M ratio is substantially influenced by the collimator type, we investigated whether an empirical linear conversion of H/M ratios between camera systems with low-energy (LE) and medium-energy (ME) collimator is possible.

Methods: We included 18 patients with parkinsonism who were referred to one of the two participating molecular imaging facilities for the evaluation of cardiac sympathetic innervation by MIBG scintigraphy. Two consecutive planar image datasets were acquired with LE and ME collimators at 4 h after MIBG administration. Linear regression analyses were performed to describe the association between the H/M ratios gained with both collimator settings, and the accuracy of a linear transfer of the H/M ratio between collimators and across centers was assessed using a leave-one-out procedure.

Results: H/M ratios acquired with LE and ME collimators showed a strong linear relationship both within each imaging facility (R = 0.99, p < 0.001 and R = 0.90, p < 0.001) and across centers (H/M-LE = 0.41 × H/M-ME + 0.63, R = 0.97, p < 0.001). A linear conversion of H/M ratios between collimators and across centers was estimated to be very accurate (mean absolute error 0.05 ± 0.04; mean relative absolute error 3.2 ± 2.6%).

Conclusions: The present study demonstrates that a simple linear conversion of H/M ratios acquired with different collimators is possible with high accuracy. This should greatly facilitate the exchange of normative data between settings and pooling of data from different institutions.

Citing Articles

Neuroimaging biomarkers in the biological definition of Parkinson's disease and dementia with Lewy bodies - EANM position on current state, unmet needs and future perspectives.

Brendel M, Guedj E, Yakushev I, Morbelli S, Hoglinger G, Tolboom N Eur J Nucl Med Mol Imaging. 2024; 51(12):3496-3500.

PMID: 38907856 PMC: 11445360. DOI: 10.1007/s00259-024-06803-w.


Application of I-MIBG myocardial maximum standardized uptake value to characterize cardiac function in patients with pheochromocytoma: comparison with echocardiography.

Nakajo M, Horizoe Y, Kawaji K, Jinguji M, Tani A, Fukukura Y Jpn J Radiol. 2022; 41(4):437-448.

PMID: 36441441 PMC: 10066163. DOI: 10.1007/s11604-022-01365-z.


Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease.

Youn J, Umemoto G, Oh E, Park J, Jang W, Oh Y Front Neurol. 2022; 13:1010006.

PMID: 36303556 PMC: 9592804. DOI: 10.3389/fneur.2022.1010006.


Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy.

Brumberg J, Schroter N, Blazhenets G, Frings L, Volkmann J, Lapa C NPJ Parkinsons Dis. 2020; 6(1):39.

PMID: 33311476 PMC: 7733458. DOI: 10.1038/s41531-020-00141-y.

References
1.
Verberne H, Feenstra C, de Jong W, Somsen G, van Eck-Smit B, Busemann Sokole E . Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study. Eur J Nucl Med Mol Imaging. 2005; 32(9):1100-7. DOI: 10.1007/s00259-005-1810-3. View

2.
Verberne H, Habraken J, van Eck-Smit B, Agostini D, Jacobson A . Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation. Eur J Nucl Med Mol Imaging. 2007; 35(3):547-53. PMC: 2275776. DOI: 10.1007/s00259-007-0611-2. View

3.
Jacobson A, Senior R, Cerqueira M, Wong N, Thomas G, Lopez V . Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010; 55(20):2212-21. DOI: 10.1016/j.jacc.2010.01.014. View

4.
Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schafers M . Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010; 37(9):1802-12. DOI: 10.1007/s00259-010-1491-4. View

5.
Bombardieri E, Giammarile F, Aktolun C, Baum R, Bischof Delaloye A, Maffioli L . 131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010; 37(12):2436-46. DOI: 10.1007/s00259-010-1545-7. View